Autoscriber, a Netherlands-based startup founded in 2021, is reimagining healthcare with its AI-powered speech recognition and natural language processing technologies. The company's slogan, "Reimagining healthcare," encapsulates its mission to revolutionize patient consultations in healthcare by automating knowledge extraction from speech and text. Autoscriber's last investment of €1.20M in a Seed Round on 11 January 2023, with backing from investors LUMO labs and BOM, underscores the confidence investors have in its potential. The startup aims to streamline administrative tasks for physicians, ultimately reducing the burden on medical professionals and freeing up time to provide better patient care. Autoscriber's focus on AI, analytics, and healthcare positions it at the forefront of innovation in the rapidly evolving healthcare industry. By enhancing capabilities across the healthcare supply chain, Autoscriber is poised to make a significant impact on improving the overall healthcare experience for both physicians and patients.
No recent news or press coverage available for Autoscriber.